Daniel Magoon
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Genomics and Chromatin Dynamics
- Chromatin Remodeling and Cancer
- Epigenetics and DNA Methylation
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 1
- Autoimmune and Inflammatory Disorders Research 1
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- Patrick Andrew Brown (19 shared papers)Edward Allan R. Sison (11 shared papers)Junwei Shi (1 shared paper)James E. Bradner (1 shared paper)Eric Wang (1 shared paper)Jun Qi (1 shared paper)Katharina Blatt (1 shared paper)Scott C. Kogan (1 shared paper)
- Journals
- Blood (10 papers)Oncotarget (3 papers)Pediatric Blood & Cancer (2 papers)Nature (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Daniel Magoon
19 papers receiving 2k citations
Daniel Magoon's Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 529
- Molecular Biology 1.1k
- Oncology 253
- Cancer Research 78
- Public Health, Environmental and Occupational Health 194
Countries citing papers authored by Daniel Magoon
This map shows the geographic impact of Daniel Magoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Magoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Magoon more than expected).
Fields of papers citing papers by Daniel Magoon
This network shows the impact of papers produced by Daniel Magoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Magoon. The network helps show where Daniel Magoon may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Magoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1587 |
| 2 | 2015 | 108 | |
| 3 | 2013 | 91 | |
| 4 | 2017 | 65 | |
| 5 | 2016 | 63 | |
| 6 | 2014 | 54 | |
| 7 | 2015 | 33 | |
| 8 | 2013 | 27 | |
| 9 | 2012 | 7 | |
| 10 | 2013 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2013 | 5 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 1 | |
| 15 | 2011 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2015 | 1 |
About Daniel Magoon
Daniel Magoon is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Molecular Biology and Nuclear Energy and Engineering, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (11 papers), Chemokine receptors and signaling (7 papers), Hematopoietic Stem Cell Transplantation (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hematology (529 citations), Molecular Biology (1.1k citations), Oncology (253 citations), Cancer Research (78 citations) and Public Health, Environmental and Occupational Health (194 citations). Daniel Magoon has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Patrick Andrew Brown, Edward Allan R. Sison, Junwei Shi, James E. Bradner, Eric Wang, Jun Qi, Katharina Blatt, Scott C. Kogan, Peter Valent and Amy Rappaport. Their work appears in journals such as Blood, Oncotarget, Pediatric Blood & Cancer, Nature and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.